Nanotechnology Stocks To Follow Now – February 01st

OSI Systems, NVE, and Clene are the three Nanotechnology stocks to watch today, according to MarketBeat’s stock screener tool. Nanotechnology stocks are publicly traded companies that are involved in the research, development, and commercialization of products and technologies related to nanotechnology, which involves manipulating materials at the atomic or molecular scale. These stocks are often associated with innovative advancements in various industries such as healthcare, electronics, energy, and materials. Investors interested in capitalizing on the potential growth and impact of nanotechnology can invest in these stocks to gain exposure to this rapidly growing sector. These companies had the highest dollar trading volume of any Nanotechnology stocks within the last several days.

OSI Systems (OSIS)

OSI Systems, Inc. designs and manufactures electronic systems and components. It operates in three segments: Security, Healthcare, and Optoelectronics and Manufacturing. The Security segment offers baggage and parcel inspection, cargo and vehicle inspection, hold baggage and people screening, radiation monitoring, explosive and narcotics trace detection systems, and optical inspection systems under the Rapiscan name.

Shares of NASDAQ OSIS traded up $0.24 during trading hours on Friday, reaching $196.44. 177,324 shares of the stock were exchanged, compared to its average volume of 206,769. The stock’s fifty day simple moving average is $175.03 and its 200 day simple moving average is $155.50. The firm has a market capitalization of $3.30 billion, a price-to-earnings ratio of 25.28, a P/E/G ratio of 1.66 and a beta of 1.19. OSI Systems has a 52 week low of $126.57 and a 52 week high of $201.42. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.25 and a current ratio of 1.88.

NVE (NVEC)

NVE Corporation develops and sells devices that use spintronics, a nanotechnology that relies on electron spin to acquire, store, and transmit information in the United States and internationally. The company manufactures spintronic products, including sensors and couplers for use in acquiring and transmitting data.

NVEC stock traded down $0.04 during trading hours on Friday, hitting $71.66. 81,181 shares of the stock were exchanged, compared to its average volume of 24,133. The company has a 50-day simple moving average of $78.70 and a two-hundred day simple moving average of $79.24. The firm has a market capitalization of $346.83 million, a P/E ratio of 23.12 and a beta of 1.12. NVE has a 12 month low of $67.35 and a 12 month high of $90.24.

Clene (CLNN)

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases.

NASDAQ:CLNN traded down $0.26 during mid-day trading on Friday, reaching $4.49. 60,244 shares of the company’s stock were exchanged, compared to its average volume of 63,018. Clene has a one year low of $3.82 and a one year high of $10.65. The business’s fifty day simple moving average is $4.75 and its two-hundred day simple moving average is $5.05. The firm has a market capitalization of $37.04 million, a PE ratio of -0.85 and a beta of 0.25.